Higher HRH1 expression by tumor-associated macrophages (TAMs) was shown to accelerate tumor growth by suppressing the cluster of differentiation-positive (CD8+) T-cell activity, and antihistamine treatment was shown to augment the effectiveness of immune checkpoint blockade (ICB) therapies in lung cancer and melanoma [20]. The gene discussed is HRH1; the disease is melanoma.